Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 17, Issue 14, Pages 1547-1571
Publisher
Future Medicine Ltd
Online
2016-08-26
DOI
10.2217/pgs-2016-0095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenomic or -epigenomic biomarkers in drug treatment: Two sides of the same medal?
- (2016) M Ingelman-Sundberg et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor
- (2016) Wenwei Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear receptors and drug metabolism for the personalization of cancer therapy
- (2016) Erika Cecchin et al. Expert Opinion on Drug Metabolism & Toxicology
- Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment
- (2016) W. D. Hedrich et al. MOLECULAR CANCER THERAPEUTICS
- CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
- (2016) Elisa M Noll et al. NATURE MEDICINE
- Precision Medicine and Rare Genetic Variants
- (2016) Volker M. Lauschke et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Regulation of gene expression by CAR: an update
- (2015) Kaoru Kobayashi et al. ARCHIVES OF TOXICOLOGY
- HNF1B polymorphism influences the prognosis of endometrial cancer patients: a cohort study
- (2015) Vincenzo Dario Mandato et al. BMC CANCER
- Activation Status of the Pregnane X Receptor Influences Vemurafenib Availability in Humanized Mouse Models
- (2015) A. Kenneth MacLeod et al. CANCER RESEARCH
- Targeting xenobiotic receptors PXR and CAR in human diseases
- (2015) Monimoy Banerjee et al. DRUG DISCOVERY TODAY
- Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy
- (2015) Elena De Mattia et al. DRUG RESISTANCE UPDATES
- Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma
- (2015) Meta H. M. Diekstra et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Hepatocyte Nuclear Factor 4α (HNF4α) in Cell Proliferation and Cancer
- (2015) Chad Walesky et al. GENE EXPRESSION
- Clinical validity of aDPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines
- (2015) Giuseppe Toffoli et al. INTERNATIONAL JOURNAL OF CANCER
- Biomarkers for personalized oncology: recent advances and future challenges
- (2015) Madhu Kalia METABOLISM-CLINICAL AND EXPERIMENTAL
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients
- (2015) Sylvia Chen et al. Pharmacogenetics and Genomics
- Polymorphisms inSLCO1B3andNR1I2as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination
- (2015) Litaty Céphanoée Mbatchi et al. PHARMACOGENOMICS
- A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients
- (2015) S Chen et al. PHARMACOGENOMICS JOURNAL
- HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
- (2015) Filipa Lopes-Coelho et al. TUMOR BIOLOGY
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
- (2015) Ken-ichi Fujita WORLD JOURNAL OF GASTROENTEROLOGY
- Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
- (2015) Wafa Hassen et al. Oncotarget
- Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival
- (2015) Yasuaki Amano et al. Oncotarget
- Regulation of Multidrug Resistance Proteins by Genistein in a Hepatocarcinoma Cell Line: Impact on Sorafenib Cytotoxicity
- (2015) Juan Pablo Rigalli et al. PLoS One
- Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
- (2014) Feifei Xu et al. Cancer Cell International
- Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents
- (2014) R Donald Harvey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibition of Cell Death and Induction of G2 Arrest Accumulation in Human Ovarian Clear Cells by HNF-1β Transcription Factor
- (2014) Hiroshi Shigetomi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients
- (2014) C. Narjoz et al. INVESTIGATIONAL NEW DRUGS
- Expression of Bile Duct Transcription Factor HNF1β Predicts Early Tumor Recurrence and Is a Stage-Independent Prognostic Factor in Hepatocellular Carcinoma
- (2014) Ray-Hwang Yuan et al. JOURNAL OF GASTROINTESTINAL SURGERY
- HNF4α Induced Chemosensitivity to Oxaliplatin and 5-FU Mediated by OCT1 and CNT3 in Renal Cell Carcinoma
- (2014) Yohannes Hagos et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Constitutive Androstane Receptor Ligands Modulate the Anti-Tumor Efficacy of Paclitaxel in Non-Small Cell Lung Cancer Cells
- (2014) Heidge Fukumasu et al. PLoS One
- Tissue-specific regulation of pregnane X receptor in cancer development and therapy
- (2014) Delira Robbins et al. Cell and Bioscience
- Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
- (2013) B Beuselinck et al. BRITISH JOURNAL OF CANCER
- Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro
- (2013) Juan Pablo Rigalli et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing
- (2013) K E Caudle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients
- (2013) Sin-Chi Chew et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond
- (2013) Xiaojuan Chai et al. Expert Opinion on Drug Metabolism & Toxicology
- Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma
- (2013) Ju Hyun Shim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment
- (2013) Elena De Mattia et al. Pharmacogenetics and Genomics
- Pharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?
- (2013) Elena De Mattia et al. PHARMACOGENOMICS
- Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
- (2012) Yakun Chen et al. BIOCHEMICAL PHARMACOLOGY
- HNF4α: a new biomarker in colon cancer?
- (2012) Karthikeyani Chellappa et al. Biomarkers in Medicine
- The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies
- (2012) D. Wang et al. BLOOD
- Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response
- (2012) Satyanarayana R. Pondugula et al. CANCER LETTERS
- Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective
- (2012) Bret D. Wallace et al. DRUG METABOLISM REVIEWS
- PXR-mediated P-glycoprotein induction by small molecule tyrosine kinase inhibitors
- (2012) S. Harmsen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients
- (2012) Nelson L. S. Tang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the milan criteria in transplantable hepatocellular carcinoma: A retrospective analysis based on tissue microarrays
- (2012) Ju Hyun Shim et al. LIVER TRANSPLANTATION
- miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
- (2012) Eva Dreussi et al. PHARMACOGENOMICS
- SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia
- (2012) Onkar Singh et al. PLoS One
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes
- (2011) Chun-Fang Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells
- (2011) Agnes Basseville et al. Molecular Cancer
- Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response
- (2011) Alexander M Cressman et al. Expert Review of Clinical Pharmacology
- Cross-talk between androgen receptor and pregnane and xenobiotic receptor reveals existence of a novel modulatory action of anti-androgenic drugs
- (2010) Subodh Kumar et al. BIOCHEMICAL PHARMACOLOGY
- Regulation of drug resistance by human pregnane X receptor in breast cancer
- (2010) Yakun Chen et al. CANCER BIOLOGY & THERAPY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
- (2010) A. A. M. van der Veldt et al. CLINICAL CANCER RESEARCH
- HNF4α—role in drug metabolism and potential drug target?
- (2010) Wendy W Hwang-Verslues et al. CURRENT OPINION IN PHARMACOLOGY
- Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
- (2010) Caroline Raynal et al. Molecular Cancer
- Orphan Nuclear Receptors as Targets for Drug Development
- (2010) Subhajit Mukherjee et al. PHARMACEUTICAL RESEARCH
- MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
- (2010) Valli De Re et al. TUMOR BIOLOGY
- PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line
- (2009) Stefan Harmsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics
- (2009) David R. Gandara et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
- (2009) Nielka P. van Erp et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Pregnane X Receptor with Multidrug Resistance-Related Protein 3 and its Role in Human Colon Cancer Chemoresistance
- (2009) Heng Jiang et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients
- (2008) E. Sandanaraj et al. CLINICAL CANCER RESEARCH
- Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer
- (2008) D. Gupta et al. CLINICAL CANCER RESEARCH
- Regulation of Hepatocyte Nuclear Factor 4α-mediated Transcription
- (2008) Frank J. Gonzalez Drug Metabolism and Pharmacokinetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More